BYSI - New CFO for BeyondSpring

BeyondSpring (BYSI) has appointed Elizabeth Czerepak as Chief Financial Officer, effective immediately. The company's subsidiary, Seed Therapeutics has appointed Edward Liu as Chief Financial Officer. Mr. Liu will also retain his responsibilities as CFO of BeyondSpring, China. Ms. Czerepak recently served as CFO and Chief Business Officer for Genevant Sciences.The company previously announced the receipt of two Breakthrough Therapy Designations in both the U.S. and China for Plinabulin in the chemotherapy-induced neutropenia ((CIN)).

For further details see:

New CFO for BeyondSpring